These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2962092)

  • 21. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
    Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
    Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
    Klingemann HG; Shepherd JD; Reece DE; Barnett MJ; Nantel SH; Sutherland HJ; Spinelli JJ; Phillips GL
    Bone Marrow Transplant; 1994; 14 Suppl 4():S14-8. PubMed ID: 7728119
    [No Abstract]   [Full Text] [Related]  

  • 23. [Whole body irradiation before bone marrow transplantation].
    Jorge L; Pereira ME; de Matos H; Patrício MB
    Acta Med Port; 1990; 3(6):337-40. PubMed ID: 2089854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Veno-occlusive disease of the liver after bone marrow transplantation. Report of the symposium Autograft in France and the group of study of bone marrow transplantation. France Auto-Greffe et le Groupe d'Etude de la Greffe de Moelle osseuse].
    Rio B; Cahn JY; Attal M; Drouet L; Scrobohaci ML; Degos F; Degott C; Bearman SI; Grañena A; Blaise D
    Presse Med; 1994 Sep 3-10; 23(26):1217-22. PubMed ID: 7831216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.
    Lassau N; Leclère J; Auperin A; Bourhis JH; Hartmann O; Valteau-Couanet D; Benhamou E; Bosq J; Ibrahim A; Girinski T; Pico JL; Roche A
    Radiology; 1997 Aug; 204(2):545-52. PubMed ID: 9240551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation.
    Qiao J; Fu J; Fang T; Huang Y; Mi H; Yang N; Chen C; Xu K; Zeng L
    Exp Mol Pathol; 2015 Feb; 98(1):73-8. PubMed ID: 25533545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation.
    Fried MW; Duncan A; Soroka S; Connaghan DG; Farrand A; Peter J; Strauss RM; Boyer TD; McDonald GB
    Bone Marrow Transplant; 2001 Mar; 27(6):635-9. PubMed ID: 11319594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation.
    Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Espérou H; Lehn P; Faure P; Drouet L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):1-3. PubMed ID: 2349075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
    Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Müller I; Stein J; Wynn R; Greil J; Sykora KW; Matthes-Martin S; Führer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Körholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin KM; Peters C; Dini G
    Lancet; 2012 Apr; 379(9823):1301-9. PubMed ID: 22364685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute renal failure secondary to hepatic veno-occlusive disease in a bone marrow transplant patient].
    Borrego FJ; Viedma G; Pérez del Barrio P; Gil JM; de Santis-Scoccia C; Ramírez Huerta JM; Alcalá A; Pérez Bañasco V
    Nefrologia; 2003; 23(4):350-4. PubMed ID: 14558335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
    Salat C; Holler E; Wolf C; Kolb HJ; Reinhardt B; Pihusch R; Krämling HJ; Heinemann V; Haller M; Hiller E
    Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver.
    Fisher DC; Vredenburgh JJ; Petros WP; Hussein A; Berry DA; Elkordy M; Rubin P; Gilbert CJ; Peters WP
    Bone Marrow Transplant; 1998 Jan; 21(2):117-22. PubMed ID: 9489626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic venocclusive disease after bone-marrow transplantation: diagnosis with duplex sonography.
    Kriegshauser JS; Charboneau JW; Letendre L
    AJR Am J Roentgenol; 1988 Feb; 150(2):289-90. PubMed ID: 3276087
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation.
    Morio S; Oh H; Hirasawa A; Aotsuka N; Nakamura H; Asai T; Yoshida S; Ito M
    Bone Marrow Transplant; 1991 Aug; 8(2):147-9. PubMed ID: 1933057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation.
    Bearman SI; Hinds MS; Wolford JL; Petersen FB; Nugent DL; Slichter SJ; Shulman HM; McDonald GB
    Bone Marrow Transplant; 1990 Jun; 5(6):407-11. PubMed ID: 2369681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokines in veno-occlusive disease of the liver after bone marrow transplantation.
    Remberger M; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3533-4. PubMed ID: 8540087
    [No Abstract]   [Full Text] [Related]  

  • 37. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.
    Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC
    Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
    Rapoport AP; Doyle HR; Starzl T; Rowe JM; Doeblin T; DiPersio JF
    Bone Marrow Transplant; 1991 Nov; 8(5):421-4. PubMed ID: 1768978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications of allogeneic hematopoietic stem cell transplantation.
    Arnaout K; Patel N; Jain M; El-Amm J; Amro F; Tabbara IA
    Cancer Invest; 2014 Aug; 32(7):349-62. PubMed ID: 24902046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic complications after bone marrow transplantation.
    Mieli-Vergani G
    Bone Marrow Transplant; 1993; 12 Suppl 1():96-7. PubMed ID: 8374577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.